The first thing Oscar Kirby said when I sat down with him at the Knoxville Community Action Agency in late January was that he almost didn’t come. “I’m not really a ‘talk about my problems’ kind of person,” he told me, straightening in his chair. He’d driven 20 minutes across town on a Tuesday morning, and he still looked like he was deciding whether to stay.
A community health navigator at the agency had referred Oscar’s story to our publication after working with him through open enrollment season. She described him only as “a man who needed help and almost didn’t accept it.” When I finally met him in person, that description felt exactly right.
A Career Built on Stability — and Then a Gap in Coverage
Oscar, 65, spent 38 years as a petroleum engineer, mostly in field operations across the Southeast. He and his wife Carol, 62, have been married for 24 years and live in a three-bedroom house in West Knoxville that they’ve owned since 2003. Their two kids are grown. Carol worked as a hospital administrator for nearly two decades before retiring in October 2025.
For years, their health coverage came through Carol’s employer plan — a comprehensive group policy that covered both of them. Oscar manages Type 2 diabetes, high blood pressure, and high cholesterol. Under Carol’s plan, their combined prescriptions ran about $85 a month. It was manageable, predictable. They’d budgeted around it for years.
Oscar turned 65 in August 2025, which made him eligible for Medicare. But as long as Carol was working and they had employer coverage, he’d held off on enrolling in Part D — the prescription drug component. When Carol retired two months later, that coverage ended. Oscar enrolled in a standalone Part D plan during a Special Enrollment Period. It was the first time he’d had to navigate Medicare on his own.
“I thought I understood it,” he told me. “I’m an engineer. I read documents for a living. But the plan comparison tool was like reading a foreign language with dollar signs.”
The Prescription That Changed Everything
Three of Oscar’s medications — metformin, lisinopril, and atorvastatin — are generics and relatively inexpensive under most Part D plans. The fourth one wasn’t. His endocrinologist had prescribed Jardiance, a brand-name diabetes medication, in early 2024 after his A1C numbers climbed despite other treatments.
Under Carol’s employer plan, Jardiance had cost Oscar around $45 a month after negotiated rates. Under the Part D plan he enrolled in — a mid-tier option he’d selected partly because the monthly premium was low — Jardiance landed in Tier 4. His cost-share: $280 a month for that drug alone. According to Medicare.gov, plan formularies and tier placements vary significantly, and a drug’s cost-share can differ by hundreds of dollars across competing plans.
Oscar didn’t realize this until his first trip to the pharmacy in November 2025. “The pharmacist read me the total and I thought she made a mistake,” he said. “I actually asked her to run it again.”
The Weight of Everything Else
The prescription shock didn’t arrive in isolation. When I asked Oscar to walk me through the fall of 2025, it became clear that multiple financial pressures had converged at once — the kind of compounding stress that’s hard to explain to someone who hasn’t lived it.
In November, a roofing contractor told Oscar and Carol their roof needed full replacement. The estimate came in at $14,200. The roof had been flagged in their last home inspection years ago, but they’d patched it. Now the patches weren’t holding. “We keep putting it off,” Oscar said quietly. “We’re still putting it off.”
Meanwhile, Oscar has been sending $450 a month to his daughter Maya, 31, who lost her marketing job in Cincinnati in September 2025 and is job hunting while supporting a toddler. Oscar doesn’t talk about this casually. When I brought it up — the navigator had mentioned it — he paused for a long moment before answering. “She didn’t ask me to stop. I’m not going to stop,” he said. “That’s not up for discussion.”
Oscar’s 401(k) held approximately $89,000 — savings he’d accumulated over nearly four decades of work. He was reluctant to touch it. “That’s retirement money. The moment I start pulling from that for prescriptions, I’ve lost something I can’t get back,” he explained. His pride wasn’t irrational. It was the logic of a man who had planned carefully for decades and was watching the plan strain at its seams.
By December 2025, he had quietly stopped filling his Jardiance prescription. He told Carol it was backordered. He told himself he’d figure out an alternative. He did not tell his doctor.
The Turning Point: A Medicare Plan Comparison He Almost Skipped
The Knoxville Community Action Agency runs a State Health Insurance Assistance Program counseling office — known as SHIP — where trained volunteers help Medicare beneficiaries compare plans at no cost. Oscar’s primary care physician had mentioned it offhand during an appointment in December. Oscar ignored the suggestion for three weeks.
“I didn’t want to sit across from someone and explain that I couldn’t afford my own medication,” he told me. “That’s a hard thing to say out loud when you’ve worked your whole life.”
He went in January 2026, during the Medicare Advantage and Part D open enrollment period, which runs through March 31 each year according to Medicare.gov. The SHIP counselor — a retired nurse named Donna — ran Oscar’s four medications through the Medicare Plan Finder tool across every Part D plan available in his zip code.
Oscar switched plans before the March 31 deadline. The new coverage took effect April 1, 2026. His Jardiance cost-share under the new plan: $95 a month — still more than the $45 he paid under Carol’s employer plan, but $185 less per month than he’d been paying since November.
Where Things Stand Now — and What’s Still Unresolved
When I followed up with Oscar by phone in mid-March, he sounded different than he had in January — steadier, though not exactly relieved. He’d restarted Jardiance in February, once he knew the plan switch was locked in. His doctor had adjusted his other medications slightly to account for the gap months. He hadn’t told Carol about stopping the medication. “She would have insisted on cutting somewhere else first,” he said. “Probably her own prescriptions.”
The roof remains unrepaired. Oscar has gotten a second estimate — $13,600 — and is weighing whether to take a small loan against his home equity or wait until Maya is back on her feet and he can reallocate that $450 a month. He has not yet decided. He is still sending Maya the money.
The partial Extra Help application is still pending as of this writing. If approved, Oscar could see his drug costs drop further — potentially to near-zero co-pays on generics and capped amounts on brand-names under the Social Security Administration’s Low Income Subsidy program. Donna at the SHIP office told him it could take six to eight weeks to process.
The numbers are better. They’re not good. Oscar knows the difference, and he said so plainly when I asked him how he felt about where things stood. “Better than I was. Not where I need to be. The roof’s still leaking. Maya’s still looking for work. Carol and I are still having conversations we shouldn’t have to be having at this point in our lives.” He paused. “But I’m taking my medication again. That part, I fixed.”
There’s something that stays with me about Oscar Kirby — not the formulary tiers or the enrollment windows or the dollar-amount delta, though those matter. It’s the image of a man who spent almost four months quietly skipping a medication he needed, in a house with a failing roof, telling himself he had it under control. He’s not unique in that. He’s just the one who agreed to talk to me about it.
Related: I Lost Nearly $500 a Month to a Rule I Didn’t Know Existed — Then Congress Finally Repealed It
Leave a Reply